BioXcel's Ch. 11 Stayed Securities Settlement, Judge Says
BioXcel Therapeutics' Chapter 11 filing paused a securities class action against it, a Delaware bankruptcy judge ruled Monday, after a federal court had pressed the life sciences group for a more...To view the full article, register now.
Already a subscriber? Click here to view full article